Rethinking clinical response and outcome assessment in a biologic age.

about

Rethinking clinical response and outcome assessment in a biologic age.

Item

http://www.wikidata.org/entity/Q38480777

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Rethinking clinical response and outcome assessment in a biologic age.

@en

type

Item

label

Rethinking clinical response and outcome assessment in a biologic age.

@en

prefLabel

Rethinking clinical response and outcome assessment in a biologic age.

@en

P1476

Rethinking clinical response and outcome assessment in a biologic age.

@en

P2093

Bruce D Cheson

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

P2888

s11912-015-0452-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-015-0452-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1035504573

http://www.w3.org/2001/XMLSchema#string

P698

25975729

http://www.w3.org/2001/XMLSchema#string

Rethinking clinical response and outcome assessment in a biologic age.

about

Rethinking clinical response and outcome assessment in a biologic age.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698